Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CLINICA 100 TOP 10: Cardinal Health

This article was originally published in Clinica

Executive Summary

Cardinal Health retains its No 7 spot in this year's Clinica 100 league table. Cardinal Health made one small acquisition in 2014, acquiring AccessClosure, a maker of extravascular closure devices, for $320m. However, this year it pushed the boat out and signed a $1.94bn deal to acquire Johnson & Johnson’s interventional cardiology business Cordis, the one-time leader in coronary stents. The acquisition ties in with Cardinal Health’s strategy to offer high-value but commoditized products in a cost-efficient way.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel